Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Alessandri and Francesco Pugliese.
Connection Strength
2.514
-
Acute Kidney Injury and COVID-19: A Picture from an Intensive Care Unit. Blood Purif. 2021; 50(6):767-771.
Score: 0.231
-
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
Score: 0.230
-
Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021 04; 93(4):2210-2220.
Score: 0.228
-
Prone Positioning for ARDS: still misunderstood and misused. J Thorac Dis. 2018 Jun; 10(Suppl 17):S2079-S2082.
Score: 0.193
-
Intermittent extracorporeal CO2 removal in chronic obstructive pulmonary disease patients: a fiction or an option. Curr Opin Crit Care. 2018 Feb; 24(1):29-34.
Score: 0.188
-
Mechanical ventilation: we have come a long way but still have a long road ahead. Lancet Respir Med. 2017 12; 5(12):922-924.
Score: 0.185
-
The Role of Rescue Therapies in the Treatment of Severe ARDS. Respir Care. 2018 Jan; 63(1):92-101.
Score: 0.185
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
Score: 0.060
-
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. Int J Cardiol. 2021 09 15; 339:235-242.
Score: 0.060
-
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022 Feb; 50(1):83-92.
Score: 0.060
-
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
Score: 0.059
-
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
Score: 0.058
-
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? J Thromb Thrombolysis. 2021 Jul; 52(1):105-110.
Score: 0.058
-
Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital. Int J Antimicrob Agents. 2021 Jan; 57(1):106245.
Score: 0.057
-
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
Score: 0.057
-
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II). Cardiovasc Diabetol. 2020 10 01; 19(1):164.
Score: 0.057
-
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract. 2020 Nov; 169:108454.
Score: 0.056
-
Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study. Crit Care Explor. 2020 Sep; 2(9):e0220.
Score: 0.056
-
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19. Br J Haematol. 2020 08; 190(4):e214-e218.
Score: 0.056
-
Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
Score: 0.056
-
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
Score: 0.056
-
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec; 30(12):6808-6817.
Score: 0.056
-
Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal. 2021 07 10; 35(2):139-142.
Score: 0.056
-
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
Score: 0.055
-
Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
Score: 0.055
-
Extracorporeal CO2 Removal May Improve Renal Function of Patients with Acute Respiratory Distress Syndrome and Acute Kidney Injury: An Open-Label, Interventional Clinical Trial. Am J Respir Crit Care Med. 2018 09 01; 198(5):687-690.
Score: 0.049